Illumina (ILMN) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Illumina (ILMN) is Neutral.

The composite score behind that read is +0.18, weighing +0.11 of bullish evidence against -0.09 bearish.

Illumina last closed at $278.17, +5.14% on the session.

Against the IVW growth benchmark the position is +4.34% over the forecast window.

The read is built from 15 underlying insights — 6 bullish and 9 bearish.

Agreement across those insights is 40%.

Illumina has no graded predictions yet. We publish our accuracy across thousands of stocks in the open, misses included.

On the fundamentals StockMap ranks Illumina in the 14th percentile on valuation and the 88th percentile on return on equity, where 100 is best.

Illumina is classified under Health Care / Life Sciences Tools & Services, with a market capitalisation of $39.95B.

StockMap tracks Illumina as the 6th largest of the 41 companies it covers in the Life Sciences Tools & Services industry, part of the Health Care sector.

Across that group the current two-week reads are 37 Neutral, 2 Moderate Outperform and 2 Moderate Underperform.

On that composite Illumina ranks 3rd of 41 in the group, against a group median of +0.06.